Endocrine Society GUIDELINES Bundle (free trial)

Management of Individuals with Diabetes at High Risk for Hypoglycemia

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1492225

Contents of this Issue

Navigation

Page 3 of 11

4 Evaluation Table 1. Persons at High Risk for Developing Hypoglycemia • Individuals taking medications known to cause hypoglycemia (e.g., insulin, sulfonylureas, meglitinides) • Individuals with impaired kidney or liver function • Older-age patients • Preschool-age children • Individuals with a history of severe hypoglycemia • Individuals with cognitive impairment or intellectual disability that may reduce ability to respond to low blood glucose • Individuals with impaired awareness of hypoglycemia • Individuals with a longer duration of diabetes (including those using insulin for ≥5 years) • Individuals who use alcohol • Individuals with eating disorders • Individuals with irregular eating schedules • Persons that are fasting for religious or cultural reasons • Individuals with a history of untreated pituitary, adrenal, or thyroid insufficiency Adapted from American Diabetes Association Professional Practice Committee. Diabetes Care, 2022; 45(Suppl. 1): S46–S59. Table 2. Definitions of Levels of Hypoglycemia Level 1: Glucose <70 mg/dL (3.9 mmol/L) and glucose ≥54 mg/dL (3.0 mmol/L); This level of hypoglycemia should alert patients that they may need to ingest carbohydrate to prevent progressive hypoglycemia. Level 2: Glucose <54 mg/dL (3.0 mmol/L); This level of hypoglycemia is associated with increased risk for cognitive dysfunction and mortality. Level 3: A severe event characterized by altered mental and/or physical status requiring assistance; This level of hypoglycemia is life-threatening and requires emergent treatment, typically with glucagon. Adapted from Agiostratidou G, et al. Diabetes Care, 2017; 40(12): 1622–1630.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Management of Individuals with Diabetes at High Risk for Hypoglycemia